Literature DB >> 9720924

Integrin-mediated signal transduction in cells lacking focal adhesion kinase p125FAK.

K Ueki1, T Mimura, T Nakamoto, T Sasaki, S Aizawa, H Hirai, S Yano, T Naruse, Y Nojima.   

Abstract

We have previously shown that integrin-dependent tyrosine phosphorylation of p130Cas (Cas) could be induced in a mouse fibroblast cell line that does not express focal adhesion kinase p125FAK (FAK). By analyzing FAK-deficient (FAK-/-) cells transiently expressing Cas mutant proteins, we demonstrate here that the Src homology 3 (SH3) domain of Cas is indispensable for adhesion-mediated Cas phosphorylation in this mutant cell line. While the FAK directly binds to Cas-SH3, our findings imply that SH3-binding molecule(s) other than FAK might regulate Cas phosphorylation, at least in FAK-/- cells. In this regard, we observed that FAK-/- cells expressed cell adhesion kinase beta (CAKbeta), a protein tyrosine kinase of the FAK subfamily. CAKbeta expressed by FAK-/- cells was associated in vivo with Cas in a Cas-SH3-dependent manner. Moreover, integrin stimulation induces tyrosine phosphorylation of CAKbeta in FAK-/- cells. Thus, our results suggest that CAKbeta contributes to integrin-mediated signal transduction in place of FAK in FAK-deficient cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720924     DOI: 10.1016/s0014-5793(98)00862-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  The tyrosine kinase pyk2 promotes migration and invasion of glioma cells.

Authors:  Christopher A Lipinski; Nhan L Tran; Emmanuel Menashi; Carole Rohl; Jean Kloss; R Curtis Bay; Michael E Berens; Joseph C Loftus
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

Review 2.  Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function.

Authors:  Peter V Usatyuk; Viswanathan Natarajan
Journal:  Microvasc Res       Date:  2011-05-06       Impact factor: 3.514

3.  Nephrocystin interacts with Pyk2, p130(Cas), and tensin and triggers phosphorylation of Pyk2.

Authors:  T Benzing; P Gerke; K Höpker; F Hildebrandt; E Kim; G Walz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

4.  CIZ, a zinc finger protein that interacts with p130(cas) and activates the expression of matrix metalloproteinases.

Authors:  T Nakamoto; T Yamagata; R Sakai; S Ogawa; H Honda; H Ueno; N Hirano; Y Yazaki; H Hirai
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Differential expression of FAK and Pyk2 in metastatic and non-metastatic EL4 lymphoma cell lines.

Authors:  Zhihong Zhang; Stewart M Knoepp; Hsun Ku; Heather M Sansbury; Yuhuan Xie; Manpreet S Chahal; Stephen Tomlinson; Kathryn E Meier
Journal:  Clin Exp Metastasis       Date:  2011-05-01       Impact factor: 5.150

6.  The Pyk2 FERM regulates Pyk2 complex formation and phosphorylation.

Authors:  Daniel Riggs; Zhongbo Yang; Jean Kloss; Joseph C Loftus
Journal:  Cell Signal       Date:  2010-09-16       Impact factor: 4.315

7.  Regulation of c-SRC activity and function by the adapter protein CAS.

Authors:  M R Burnham; P J Bruce-Staskal; M T Harte; C L Weidow; A Ma; S A Weed; A H Bouton
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2.

Authors:  J D Owen; P J Ruest; D W Fry; S K Hanks
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

9.  The rho-specific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration.

Authors:  Zhuoming Liu; Homer C Adams; Ian P Whitehead
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

10.  Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts.

Authors:  Christopher A Lipinski; Nhan L Tran; Carole Viso; Jean Kloss; Zhongbo Yang; Michael E Berens; Joseph C Loftus
Journal:  J Neurooncol       Date:  2008-07-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.